90% are long, 10% are short on MSB. Its all about perspective. Shorts love the Bio space, most trials fail, most need CR, Most struggle to meet the high bar, set by the FDA, FACT. Its a natural fit for Shorter's. I think we focus on shorts way too much IMO.
Attention: Mesoblast Share Shorters, page-4
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
-0.045(3.07%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $5.177M | 3.686M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 10842 | $1.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 3817 | 5 |
View Market Depth
| Last trade - 12.50pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |